Rein Therapeutics Statistics
Total Valuation
RNTX has a market cap or net worth of $42.90 million. The enterprise value is $19.18 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RNTX has 21.67 million shares outstanding. The number of shares has increased by 201.87% in one year.
Current Share Class | 21.67M |
Shares Outstanding | 21.67M |
Shares Change (YoY) | +201.87% |
Shares Change (QoQ) | +8.80% |
Owned by Insiders (%) | 1.18% |
Owned by Institutions (%) | 18.43% |
Float | 19.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.73 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30
Current Ratio | 3.30 |
Quick Ratio | 3.12 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.95% and return on invested capital (ROIC) is -34.78%.
Return on Equity (ROE) | -54.95% |
Return on Assets (ROA) | -31.63% |
Return on Invested Capital (ROIC) | -34.78% |
Return on Capital Employed (ROCE) | -30.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.95M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.58% in the last 52 weeks. The beta is 2.25, so RNTX's price volatility has been higher than the market average.
Beta (5Y) | 2.25 |
52-Week Price Change | -70.58% |
50-Day Moving Average | 2.11 |
200-Day Moving Average | 2.64 |
Relative Strength Index (RSI) | 49.30 |
Average Volume (20 Days) | 26,934 |
Short Selling Information
The latest short interest is 165,216, so 0.76% of the outstanding shares have been sold short.
Short Interest | 165,216 |
Short Previous Month | 197,925 |
Short % of Shares Out | 0.76% |
Short % of Float | 0.85% |
Short Ratio (days to cover) | 1.95 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.62M |
Pretax Income | n/a |
Net Income | -29.24M |
EBITDA | -29.50M |
EBIT | -29.62M |
Earnings Per Share (EPS) | -$2.13 |
Full Income Statement Balance Sheet
The company has $17.65 million in cash and n/a in debt, giving a net cash position of $17.65 million or $0.81 per share.
Cash & Cash Equivalents | 17.65M |
Total Debt | n/a |
Net Cash | 17.65M |
Net Cash Per Share | $0.81 |
Equity (Book Value) | 95.23M |
Book Value Per Share | 2.32 |
Working Capital | 13.03M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -27.87M |
Capital Expenditures | n/a |
Free Cash Flow | -27.87M |
FCF Per Share | -$1.29 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |